Table of Contents
Introduction
Anti-tissue transglutaminase IgA antibodies (Anti-Ttg IgA) are frequently measured to diagnose and manage celiac disease. Elevated levels of these antibodies are a key marker in the assessment of gluten-related disorders.
Understanding Anti-Ttg IgA Antibodies
Anti-Ttg IgA antibodies target tissue transglutaminase, an enzyme found in the small intestine. This section explains their role in immune response, particularly in the context of celiac disease, and highlights normal versus elevated levels.
High Anti-Ttg IgA Levels: Indications and Implications
Elevated Anti-Ttg IgA levels typically suggest an autoimmune response, most commonly associated with celiac disease. Levels above 10 U/mL are often considered significant, necessitating further investigation.
Clinical Significance of High Anti-Ttg IgA Levels
High Anti-Ttg IgA levels serve as a diagnostic marker for celiac disease but may also indicate other autoimmune or inflammatory conditions. This section reviews their clinical applications and limitations.
Laihe Biotech Solutions
Laihe Biotech offers innovative diagnostic solutions for measuring Anti-Ttg IgA antibodies using advanced immunoassay technologies. Reliable detection methods and case studies are discussed in this section.
References
- Fasano, A., & Catassi, C. (2012). Current approaches to diagnosis and treatment of celiac disease: An evolving spectrum. Gastroenterology, 143(3), 602–619.
- Di Sabatino, A., & Corazza, G. R. (2009). Coeliac disease. The Lancet, 373(9673), 1480-1493.
- Rubio-Tapia, A., Ludvigsson, J. F., Brantner, T. L., Murray, J. A., & Everhart, J. E. (2012). The prevalence of celiac disease in the United States. The American Journal of Gastroenterology, 107(10), 1538-1544.
- Laihe Biotech. (2023). Diagnostic solutions for immune disorders. Retrieved from laihebiotech.com
User keyword search:Anti Ttg Iga Antibodies
Laihe Biotech brand gives you a solution